Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-31 @ 2:56 PM
Study NCT ID:
NCT02454933
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2015-05-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-14
First Submit QC Date:
None
Study First Post Date:
2015-05-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-16
Results First Submit QC Date:
None
Results First Post Date:
2018-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-06
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL